Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats
Autor(a) principal: | |
---|---|
Data de Publicação: | 2002 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/21117 |
Resumo: | Few data are available in the literature regarding the effect of pentosan polysulfate (PPS) on normal and fibrotic rat livers. In addition, the combination of PPS and carbon tetrachloride (CCl4) has not been studied so far. The objective of this study was to assess the effect of PPS on rat livers treated or not with CCl4 for the induction of liver fibrosis. The study consisted of four stages: 1) hepatic fibrosis induction with CCl4 (N = 36 rats); 2) evaluation of the effect of PPS on CCl4- induced hepatic fibrosis (N = 36 rats); 3) evaluation of the effect of higher doses of PPS in combination with CCl4 (N = 50 rats); 4) evaluation of the presence of an enzymatic inductor effect by PPS (N = 18 rats) using the sodium pentobarbital test which indirectly evaluates hepatic microsomal enzyme activity in vivo. Adult (60 to 70 days) male Wistar rats weighing 180 to 220 g were used. All animals receiving 0.5 ml 8% CCl4 (N = 36) developed hepatic fibrosis, and after 8 weeks they also developed cirrhosis. No delay or prevention of hepatic fibrosis was observed with the administration of 5 mg/kg PPS (N = 8) and 1 mg/kg PPS (N = 8) 1 h after the administration of CCl4, but the increased hepatotoxicity resulting from the combination of the two substances caused massive hepatic necrosis in most rats (N = 45). PPS (40 mg/kg) alone caused hepatic congestion only after 8 weeks, but massive hepatic necrosis was again observed in association with 0.5 ml CCl4 after 1 to 4 weeks of treatment. Unexpectedly, sleeping time increased with time of PPS administration (1, 2, or 3 weeks). This suggests that PPS does not function as an activator of the hepatic microsomal enzymatic system. Further studies are necessary in order to clarify the unexpected increase in hepatotoxicity caused by the combination of CCl4 and high doses of PPS, which results in massive hepatic necrosis. |
id |
UFRGS-2_fa6b3583349fd2fa6059d6e7da6a2596 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/21117 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Zim, Maria do Carmo AppelSilveira, Themis Reverbel daSchwartsmann, GilbertoCerski, Carlos Thadeu SchmidtMotta, Arnaldo Alves da2010-04-24T04:15:23Z20020100-879Xhttp://hdl.handle.net/10183/21117000353596Few data are available in the literature regarding the effect of pentosan polysulfate (PPS) on normal and fibrotic rat livers. In addition, the combination of PPS and carbon tetrachloride (CCl4) has not been studied so far. The objective of this study was to assess the effect of PPS on rat livers treated or not with CCl4 for the induction of liver fibrosis. The study consisted of four stages: 1) hepatic fibrosis induction with CCl4 (N = 36 rats); 2) evaluation of the effect of PPS on CCl4- induced hepatic fibrosis (N = 36 rats); 3) evaluation of the effect of higher doses of PPS in combination with CCl4 (N = 50 rats); 4) evaluation of the presence of an enzymatic inductor effect by PPS (N = 18 rats) using the sodium pentobarbital test which indirectly evaluates hepatic microsomal enzyme activity in vivo. Adult (60 to 70 days) male Wistar rats weighing 180 to 220 g were used. All animals receiving 0.5 ml 8% CCl4 (N = 36) developed hepatic fibrosis, and after 8 weeks they also developed cirrhosis. No delay or prevention of hepatic fibrosis was observed with the administration of 5 mg/kg PPS (N = 8) and 1 mg/kg PPS (N = 8) 1 h after the administration of CCl4, but the increased hepatotoxicity resulting from the combination of the two substances caused massive hepatic necrosis in most rats (N = 45). PPS (40 mg/kg) alone caused hepatic congestion only after 8 weeks, but massive hepatic necrosis was again observed in association with 0.5 ml CCl4 after 1 to 4 weeks of treatment. Unexpectedly, sleeping time increased with time of PPS administration (1, 2, or 3 weeks). This suggests that PPS does not function as an activator of the hepatic microsomal enzymatic system. Further studies are necessary in order to clarify the unexpected increase in hepatotoxicity caused by the combination of CCl4 and high doses of PPS, which results in massive hepatic necrosis.application/pdfengBrazilian journal of medical and biological research. Ribeirão Preto, SP. Vol. 35, no. 11 (Nov. 2002), p. 1339-1346FígadoCirrose hepáticaModelos animais de doençasRatosPoliéster sulfúrico de pentosanaTetracloreto de carbonoCirrhosisFibrogenesisHepatic necrosisPentosan polysulfateCarbon tetrachloridePotentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in ratsinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000353596.pdf000353596.pdfTexto completo (inglês)application/pdf3047708http://www.lume.ufrgs.br/bitstream/10183/21117/1/000353596.pdfccc15fa0ff021b1fd6c5635b3ab49dd3MD51TEXT000353596.pdf.txt000353596.pdf.txtExtracted Texttext/plain26934http://www.lume.ufrgs.br/bitstream/10183/21117/2/000353596.pdf.txtf0fa3ed460b0fdfc44d7a97dec1dfa3eMD52THUMBNAIL000353596.pdf.jpg000353596.pdf.jpgGenerated Thumbnailimage/jpeg1659http://www.lume.ufrgs.br/bitstream/10183/21117/3/000353596.pdf.jpge35cf7f505bdc2d567fb5d6affdbdd6eMD5310183/211172018-10-05 09:04:28.975oai:www.lume.ufrgs.br:10183/21117Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2018-10-05T12:04:28Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats |
title |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats |
spellingShingle |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats Zim, Maria do Carmo Appel Fígado Cirrose hepática Modelos animais de doenças Ratos Poliéster sulfúrico de pentosana Tetracloreto de carbono Cirrhosis Fibrogenesis Hepatic necrosis Pentosan polysulfate Carbon tetrachloride |
title_short |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats |
title_full |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats |
title_fullStr |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats |
title_full_unstemmed |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats |
title_sort |
Potentiation of carbon tetrachloride hepatotoxicity by pentosan polysulfate in rats |
author |
Zim, Maria do Carmo Appel |
author_facet |
Zim, Maria do Carmo Appel Silveira, Themis Reverbel da Schwartsmann, Gilberto Cerski, Carlos Thadeu Schmidt Motta, Arnaldo Alves da |
author_role |
author |
author2 |
Silveira, Themis Reverbel da Schwartsmann, Gilberto Cerski, Carlos Thadeu Schmidt Motta, Arnaldo Alves da |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Zim, Maria do Carmo Appel Silveira, Themis Reverbel da Schwartsmann, Gilberto Cerski, Carlos Thadeu Schmidt Motta, Arnaldo Alves da |
dc.subject.por.fl_str_mv |
Fígado Cirrose hepática Modelos animais de doenças Ratos Poliéster sulfúrico de pentosana Tetracloreto de carbono |
topic |
Fígado Cirrose hepática Modelos animais de doenças Ratos Poliéster sulfúrico de pentosana Tetracloreto de carbono Cirrhosis Fibrogenesis Hepatic necrosis Pentosan polysulfate Carbon tetrachloride |
dc.subject.eng.fl_str_mv |
Cirrhosis Fibrogenesis Hepatic necrosis Pentosan polysulfate Carbon tetrachloride |
description |
Few data are available in the literature regarding the effect of pentosan polysulfate (PPS) on normal and fibrotic rat livers. In addition, the combination of PPS and carbon tetrachloride (CCl4) has not been studied so far. The objective of this study was to assess the effect of PPS on rat livers treated or not with CCl4 for the induction of liver fibrosis. The study consisted of four stages: 1) hepatic fibrosis induction with CCl4 (N = 36 rats); 2) evaluation of the effect of PPS on CCl4- induced hepatic fibrosis (N = 36 rats); 3) evaluation of the effect of higher doses of PPS in combination with CCl4 (N = 50 rats); 4) evaluation of the presence of an enzymatic inductor effect by PPS (N = 18 rats) using the sodium pentobarbital test which indirectly evaluates hepatic microsomal enzyme activity in vivo. Adult (60 to 70 days) male Wistar rats weighing 180 to 220 g were used. All animals receiving 0.5 ml 8% CCl4 (N = 36) developed hepatic fibrosis, and after 8 weeks they also developed cirrhosis. No delay or prevention of hepatic fibrosis was observed with the administration of 5 mg/kg PPS (N = 8) and 1 mg/kg PPS (N = 8) 1 h after the administration of CCl4, but the increased hepatotoxicity resulting from the combination of the two substances caused massive hepatic necrosis in most rats (N = 45). PPS (40 mg/kg) alone caused hepatic congestion only after 8 weeks, but massive hepatic necrosis was again observed in association with 0.5 ml CCl4 after 1 to 4 weeks of treatment. Unexpectedly, sleeping time increased with time of PPS administration (1, 2, or 3 weeks). This suggests that PPS does not function as an activator of the hepatic microsomal enzymatic system. Further studies are necessary in order to clarify the unexpected increase in hepatotoxicity caused by the combination of CCl4 and high doses of PPS, which results in massive hepatic necrosis. |
publishDate |
2002 |
dc.date.issued.fl_str_mv |
2002 |
dc.date.accessioned.fl_str_mv |
2010-04-24T04:15:23Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/other |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/21117 |
dc.identifier.issn.pt_BR.fl_str_mv |
0100-879X |
dc.identifier.nrb.pt_BR.fl_str_mv |
000353596 |
identifier_str_mv |
0100-879X 000353596 |
url |
http://hdl.handle.net/10183/21117 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Brazilian journal of medical and biological research. Ribeirão Preto, SP. Vol. 35, no. 11 (Nov. 2002), p. 1339-1346 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/21117/1/000353596.pdf http://www.lume.ufrgs.br/bitstream/10183/21117/2/000353596.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/21117/3/000353596.pdf.jpg |
bitstream.checksum.fl_str_mv |
ccc15fa0ff021b1fd6c5635b3ab49dd3 f0fa3ed460b0fdfc44d7a97dec1dfa3e e35cf7f505bdc2d567fb5d6affdbdd6e |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
lume@ufrgs.br |
_version_ |
1817724802840920064 |